BMC Neurol

1. KOHLER M, Paul F, Janke K, Sturtz S, et al
   Comparative effectiveness of disease-modifying therapies for highly active relapsing-remitting multiple sclerosis despite previous treatment - a systematic review and network meta-analysis.
   BMC Neurol. 2025;25:328.
   

   >> Share

   
   
2. DONG H, Li M, Ma M, Qi G, et al
   A nurse-led nomogram for predicting the risk of myasthenic crisis in patients with myasthenia gravis and bulbar weakness.
   BMC Neurol. 2025;25:332.
   

   >> Share

   
   

   
   Brain

3. CHIEK TEOH CS, Dubey SG, Handel AE
   Rethinking corticosteroid therapy in autoimmune neurology.
   Brain. 2025 Aug 11:awaf292. doi: 10.1093.
   

   >> Share

   
   

   
   Intern Med

4. KAJIHARA N, Senokuchi T, Maeda S, Hanatani S, et al
   A Case Report of Graves' Disease Diagnosed during an Evaluation of an Abnormal Opacity on a Chest X-ray with a Review of The Pertinent Literature.
   Intern Med. 2025 Aug 14. doi: 10.2169/internalmedicine.5404.
   

   >> Share

   
   

   
   J Autoimmun

5. ZHU M, Li X, Zhao K, Huang Z, et al
   Altered glucose metabolism in B cells: Implications for the pathogenesis and treatment of autoimmune diseases.
   J Autoimmun. 2025;156:103472.
   

   >> Share

   
   
6. YI X, Zimath PL, Martin-Vazquez E, Oliveira JG, et al
   Transcriptomics of autoimmune diseases identifies FGFR1 as a target for pancreatic beta-cell protection.
   J Autoimmun. 2025;156:103469.
   

   >> Share

   
   
7. HEBBANDI NANJUNDAPPA R, Kolla HB, Edgar A, Leung PS, et al
   Immunological and fibrotic profiling in the NOD.c3c4 murine model of autoimmune cholangitis.
   J Autoimmun. 2025;156:103473.
   

   >> Share

   
   

   
   J Clin Endocrinol Metab

8. XU Y, Liu R, Huang L, Qin Y, et al
   Response to Letter to the Editor from Perros: Comprehensive Comparisons of Different Treatments for Active Graves Orbitopathy: A Systematic Review and Bayesian Model-Based Network Meta-Analysis.
   J Clin Endocrinol Metab. 2025 Aug 11:dgaf456. doi: 10.1210.
   

   >> Share

   
   
9. PERROS P
   Letter to the Editor from Perros: Comprehensive Comparisons of Different Treatments for Active Graves' Orbitopathy: A Systematic Review and Bayesian Model-Based Network Meta-Analysis.
   J Clin Endocrinol Metab. 2025 Aug 11:dgaf455. doi: 10.1210.
   

   >> Share

   
   

   
   J Neuroimmunol

10. BICIMVEREN MS, Ciftci SN, Alp G
    A rare cause of visual impairment in patients with multiple sclerosis: Uveitis.
    J Neuroimmunol. 2025;407:578714.
    

    >> Share

    
    
11. FAN T, Jiang Y, Hu W, Xu W, et al
    Efficacy of FcRn antagonist efgartigimod in the treatment of Miller-Fisher/Guillain-Barre overlap syndrome: Two case reports.
    J Neuroimmunol. 2025;407:578712.
    

    >> Share

    
    
12. EL-WAHSH S, Ramanathan S, Reddel S
    Clinical utility of autoantibodies in the diagnosis and management of Myasthenia gravis.
    J Neuroimmunol. 2025;407:578718.
    

    >> Share

    
    

    
    J Neurol

13. ALAM Z, Maddali A, Patel S, Weber N, et al
    Current imaging applications, radiomics, and machine learning modalities of CNS demyelinating disorders and its mimickers.
    J Neurol. 2025;272:568.
    

    >> Share

    
    
14. FILIPPI M, Amato MP, Centonze D, Gallo P, et al
    The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensus.
    J Neurol. 2025;272:565.
    

    >> Share

    
    

    
    J Pediatr

15. DE SOUZA BJ, Kassis O, Nagesh D, Ross PA, et al
    Age-Related Differences in Respiratory Outcomes Among Critically Ill Children with Guillain-Barre Syndrome.
    J Pediatr. 2025 Aug 7:114766. doi: 10.1016/j.jpeds.2025.114766.
    

    >> Share

    
    

    
    Mult Scler

16. KRAUSE N, Derad C, von Glasenapp B, Riemann-Lorenz K, et al
    Digital lifestyle management application (levidex) for empowerment and health behaviour change in early multiple sclerosis - Results of the randomised controlled POWER@MS1 trial.
    Mult Scler. 2025 Aug 12:13524585251356410. doi: 10.1177/13524585251356410.
    

    >> Share

    
    

    
    PLoS One

17. RASMUSSEN MGB, Just-Ostergaard E, Stidsen JV, Willaing I, et al
    What is the impact of structural changes in society on diabetes self-management and trajectories of HbA1c? A cohort study before, during and after the COVID-19 pandemic in people with diabetes treated at outpatient clinics.
    PLoS One. 2025;20:e0329394.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

18. ZHAO Z, Li A, Zhu Y, Cen S, et al
    Blood-labyrinth barrier damage mediated by granzymes from cytotoxic lymphocytes results in hearing loss in systemic lupus erythematosus.
    Proc Natl Acad Sci U S A. 2025;122:e2423240122.
    

    >> Share

    
    

    
    Thyroid

19. CHOU YT, Lai CC, Li CY, Shen WC, et al
    Early Statin Use Following Diagnosis of Graves' Disease Is Associated with a Reduced Risk of Moderate-to-Severe Graves' Orbitopathy in Middle-Aged Adults: Evidence from a Nationwide Taiwanese Cohort.
    Thyroid. 2025 Aug 13. doi: 10.1177/10507256251364782.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share